MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 7, 2015, Pages 332.e9-332.e18

  Qiu, Mingning ^a   Liang, Ziji ^a   Chen, Lieqian ^a   Tan, Guobin ^a   Wang, Kangning ^a   Liu, Lei ^a   Liu, Jianjun ^a   Chen, Hege ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

BMI1; E2F3; MiR 429; Renal carcinoma cells

Indexed keywords

BMI1 PROTEIN; DNA FRAGMENT; MICRORNA; MICRORNA 429; NERVE CELL ADHESION MOLECULE; PROTEIN P14; PROTEIN P16; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; BMI1 PROTEIN, HUMAN; E2F3 PROTEIN, HUMAN; MIRN429 MICRORNA, HUMAN; PRIMER DNA;

3' UNTRANSLATED REGION; ARTICLE; CANCER INHIBITION; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; CELL MOTION; CHEMISTRY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLASMID; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA PRIMERS; E2F3 TRANSCRIPTION FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; PLASMIDS; POLYCOMB REPRESSIVE COMPLEX 1; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84930572262     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.03.016     Document Type: Article

References (49)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
2. DeSantis C.E., Lin C.C., Mariotto A.B., Siegel R.L., Stein K.D., Kramer J.L., et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014, 64:252-271.
3. Chow W.H., Dong L.M., Devesa S.S. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010, 7:245-257.
4. Stadler W.M. Maturing of Renal Cancer Therapeutics. J Clin Oncol 2014, 32:722-724.
5. Mani S.A., Guo W., Liao M.-J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
6. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008, 14:818-829.
7. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
8. Angst B.D., Marcozzi C., Magee A.I. The cadherin superfamily. J Cell Sci 2001, 114:625-626.
9. Kang Y., Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279.
10. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
11. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
12. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001, 107:823-826.
13. Zhang B., Pan X., Cobb G.P., Anderson T.A. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302:1-12.
14. Feng X., Wang Z., Fillmore R., Xi Y. MiR-200, a new star miRNA in human cancer. Cancer Lett 2014, 344:166-173.
15. Mongroo P.S., Rustgi A.K. The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther 2010, 10:219-222.
16. Wang X., Chen X., Wang R., Xiao P., Xu Z., Chen L., et al. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncol Rep 2013, 30:643-650.
17. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008, 283:14910-14914.
18. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.
19. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22:894-907.
20. Tucci M., Lucarini G., Brancorsini D., Zizzi A., Pugnaloni A., Giacchetti A., et al. Involvement of E-cadherin, β-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Br J Dermatol 2007, 157:1212-1216.
21. Piunti A., Pasini D. Epigenetic factors in cancer development: polycomb group proteins. Future Oncol 2011, 7:57-75.
22. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999, 397:164-168.
23. Kim J.H., Yoon S.Y., Kim C.-N., Joo J.H., Moon S.K., Choe I.S., et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 2004, 203:217-224.
24. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001, 2:731-737.
25. Silva J., Garcia J.M., Pena C., Garcia V., Dominguez G., Suarez D., et al. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas. Clin Cancer Res 2006, 12:6929-6936.
26. Olsson A.Y., Feber A., Edwards S., Te Poele R., Giddings I., Merson S., et al. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene 2007, 26:1028-1037.
27. Sylvestre Y., De Guire V., Querido E., Mukhopadhyay U.K., Bourdeau V., Major F., et al. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 2007, 282:2135-2143.
28. Huang L., Luo J., Cai Q., Pan Q., Zeng H., Guo Z., et al. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 2011, 128:1758-1769.
29. Cooper C.S., Nicholson A.G., Foster C., Dodson A., Edwards S., Fletcher A., et al. Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Lung Cancer 2006, 54:155-162.
30. Liu L., Qiu M., Tan G., Liang Z., Qin Y., Chen L., et al. miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. J Transl Med 2014, 12:305.
31. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009, 10:704-714.
32. Ye Z.B., Ma G., Zhao Y.H., Xiao Y., Zhan Y., Jing C., et al. miR-429 inhibits migration and invasion of breast cancer cells in vitro. Int J Oncol 2015, 46:531-538.
33. Sun Y., Shen S., Liu X., Tang H., Wang Z., Yu Z., et al. MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma. Mol Cell Biochem 2014, 390:19-30.
34. Wang Y., Li M., Zang W., Ma Y., Wang N., Li P., et al. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol 2013, 36:385-394.
35. Yoshino H., Enokida H., Itesako T., Tatarano S., Kinoshita T., Fuse M., et al. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma. J Hum Genet 2013, 58:508-516.
36. Cheng T., Wang L., Li Y., Huang C., Zeng L., Yang J. Differential microRNA expression in renal cell carcinoma. Oncol Lett 2013, 6:769-776.
37. Hidaka H., Seki N., Yoshino H., Yamasaki T., Yamada Y., Nohata N., et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 2012, 3:44-57.
38. Yu J., Ohuchida K., Mizumoto K., Sato N., Kayashima T., Fujita H., et al. Research MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Cancer Res 2010, 12:13.
39. Liu X.-G., Zhu W.-Y., Huang Y.-Y., Ma L.-N., Zhou S.-Q., Wang Y.-K., et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012, 29:618-626.
40. Chang C.-J., Chao C.-H., Xia W., Yang J.-Y., Xiong Y., Li C.-W., et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011, 13:317-323.
41. Yu X., Jiang X., Li H., Guo L., Jiang W., Lu S.H. miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. Stem Cells Dev 2014, 23:576-585.
42. Calao M., Sekyere E., Cui H., Cheung B., Thomas W., Keating J., et al. Direct effects of BMI1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Oncogene 2013, 32:3616-3626.
43. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998, 92:725-734.
44. Foster C.S., Falconer A., Dodson A.R., Norman A.R., Dennis N., Fletcher A., et al. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 2004, 23:5871-5879.
45. Xiao F., Zhang W., Chen L., Chen F., Xie H., Xing C., et al. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. J Transl Med 2013, 11:195.
46. Zhou J., Cheng M., Wu M., Boriboun C., Jujo K., Xu S., et al. Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis. J Mol Cell Cardiol 2013, 60:68-71.
47. Kraljevic Pavelic S., Sedic M., Bosnjak H., Spaventi S., Pavelic K. Metastasis: new perspectives on an old problem. Mol Cancer 2011, 10:22.
48. Satelli A., Mitra A., Brownlee Z., Xeuqing X., Bellister S., Overman M.J., et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res 2015, 21:899-906.
49. Song L.-B., Li J., Liao W.-T., Feng Y., Yu C.-P., Hu L.-J., et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009, 119:3626-3636.